Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Ketamine has distinct electrophysiological and behavioral effects in depressed and healthy subjects
Allison C. Nugent, Elizabeth D. Ballard, Todd D. Gould, et al.
Molecular Psychiatry (2018) Vol. 24, Iss. 7, pp. 1040-1052
Open Access | Times Cited: 218

Showing 1-25 of 218 citing articles:

Rapid‐acting antidepressant ketamine, its metabolites and other candidates: A historical overview and future perspective
Kenji Hashimoto
Psychiatry and Clinical Neurosciences (2019) Vol. 73, Iss. 10, pp. 613-627
Open Access | Times Cited: 285
Gamma oscillations as a biomarker for major depression: an emerging topic
Paul J. Fitzgerald, Brendon O. Watson
Translational Psychiatry (2018) Vol. 8, Iss. 1
Open Access | Times Cited: 277
Blinding and expectancy confounds in psychedelic randomized controlled trials
Suresh Muthukumaraswamy, Anna Forsyth, Thomas Lumley
Expert Review of Clinical Pharmacology (2021) Vol. 14, Iss. 9, pp. 1133-1152
Closed Access | Times Cited: 208
Molecular mechanisms underlying the antidepressant actions of arketamine: beyond the NMDA receptor
Wei Yan, Lijia Chang, Kenji Hashimoto
Molecular Psychiatry (2021) Vol. 27, Iss. 1, pp. 559-573
Open Access | Times Cited: 178
Molecular and cellular mechanisms underlying the antidepressant effects of ketamine enantiomers and its metabolites
Chun Yang, Jianjun Yang, Ailin Luo, et al.
Translational Psychiatry (2019) Vol. 9, Iss. 1
Open Access | Times Cited: 163
Psychedelics in Psychiatry: Neuroplastic, Immunomodulatory, and Neurotransmitter Mechanisms
Antonio Inserra, Danilo De Gregorio, Gabriella Gobbi
Pharmacological Reviews (2020) Vol. 73, Iss. 1, pp. 202-277
Open Access | Times Cited: 161
Modulation of the antidepressant effects of ketamine by the mTORC1 inhibitor rapamycin
Chadi G. Abdallah, Lynnette A. Averill, Ralitza Gueorguieva, et al.
Neuropsychopharmacology (2020) Vol. 45, Iss. 6, pp. 990-997
Open Access | Times Cited: 150
The role of dissociation in ketamine’s antidepressant effects
Elizabeth D. Ballard, Carlos A. Zarate
Nature Communications (2020) Vol. 11, Iss. 1
Open Access | Times Cited: 140
Ketamine for the treatment of major depression: a systematic review and meta-analysis
Stevan Nikolin, Anthony Rodgers, Andreas Schwaab, et al.
EClinicalMedicine (2023) Vol. 62, pp. 102127-102127
Open Access | Times Cited: 60
Ketamine in neuropsychiatric disorders: an update
Jenessa N. Johnston, Bashkim Kadriu, Christoph Kraus, et al.
Neuropsychopharmacology (2023) Vol. 49, Iss. 1, pp. 23-40
Closed Access | Times Cited: 47
Perioperative Adjunctive Esketamine for Postpartum Depression Among Women Undergoing Elective Cesarean Delivery
Yu Chen, Yu Guo, Han Wu, et al.
JAMA Network Open (2024) Vol. 7, Iss. 3, pp. e240953-e240953
Open Access | Times Cited: 18
Brain region–specific action of ketamine as a rapid antidepressant
Min Chen, Shuangshuang Ma, Hanxiao Liu, et al.
Science (2024) Vol. 385, Iss. 6709
Closed Access | Times Cited: 17
Glutamatergic Neurotransmission: Pathway to Developing Novel Rapid-Acting Antidepressant Treatments
Bashkim Kadriu, Laura Musazzi, Ioline D. Henter, et al.
The International Journal of Neuropsychopharmacology (2018) Vol. 22, Iss. 2, pp. 119-135
Open Access | Times Cited: 143
Default Mode Connectivity in Major Depressive Disorder Measured Up to 10 Days After Ketamine Administration
Jennifer W. Evans, Joanna Szczepanik, Nancy E. Brutsché, et al.
Biological Psychiatry (2018) Vol. 84, Iss. 8, pp. 582-590
Open Access | Times Cited: 140
( 2R,6R )-hydroxynorketamine exerts mGlu 2 receptor-dependent antidepressant actions
Panos Zanos, Jaclyn N. Highland, Brent W. Stewart, et al.
Proceedings of the National Academy of Sciences (2019) Vol. 116, Iss. 13, pp. 6441-6450
Open Access | Times Cited: 128
Features of dissociation differentially predict antidepressant response to ketamine in treatment-resistant depression
Mark J. Niciu, Bridget Shovestul, Brittany A. Jaso, et al.
Journal of Affective Disorders (2018) Vol. 232, pp. 310-315
Open Access | Times Cited: 116
Efficacy of single and repeated administration of ketamine in unipolar and bipolar depression: a meta-analysis of randomized clinical trials
Joanna Kryst, Paweł Kawalec, Alicja Mikrut Mitoraj, et al.
Pharmacological Reports (2020) Vol. 72, Iss. 3, pp. 543-562
Open Access | Times Cited: 111
Stress-sensitive antidepressant-like effects of ketamine in the mouse forced swim test
Paul J. Fitzgerald, Jessica Yen, Brendon O. Watson
PLoS ONE (2019) Vol. 14, Iss. 4, pp. e0215554-e0215554
Open Access | Times Cited: 90
Ketamine—50 years in use: from anesthesia to rapid antidepressant effects and neurobiological mechanisms
Samuel Kohtala
Pharmacological Reports (2021) Vol. 73, Iss. 2, pp. 323-345
Open Access | Times Cited: 90
Ketamine modulates fronto-striatal circuitry in depressed and healthy individuals
Anahit Mkrtchian, Jennifer W. Evans, Christoph Kraus, et al.
Molecular Psychiatry (2020) Vol. 26, Iss. 7, pp. 3292-3301
Open Access | Times Cited: 83
Comprehensive assessment of side effects associated with a single dose of ketamine in treatment-resistant depression
Elia E. Acevedo-Diaz, Grace W. Cavanaugh, Dede Greenstein, et al.
Journal of Affective Disorders (2019) Vol. 263, pp. 568-575
Open Access | Times Cited: 81
The role of NMDA receptor in neurobiology and treatment of major depressive disorder: Evidence from translational research
Meysam Amidfar, Marie Woelfer, Gislaine Z. Réus, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2019) Vol. 94, pp. 109668-109668
Closed Access | Times Cited: 75
Ketamine for depression
Luke A. Jelen, James Stone
International Review of Psychiatry (2021) Vol. 33, Iss. 3, pp. 207-228
Closed Access | Times Cited: 70
Imaging the effect of ketamine on synaptic density (SV2A) in the living brain
Sophie Holmes, Sjoerd J. Finnema, Mika Naganawa, et al.
Molecular Psychiatry (2022) Vol. 27, Iss. 4, pp. 2273-2281
Open Access | Times Cited: 53
International pooled patient-level meta-analysis of ketamine infusion for depression: In search of clinical moderators
Rebecca B. Price, Nicholas Kissel, Andrew Baumeister, et al.
Molecular Psychiatry (2022) Vol. 27, Iss. 12, pp. 5096-5112
Open Access | Times Cited: 52
Page 1 - Next Page

Scroll to top